摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2'-Carbamoyl-3'-methoxyoxanilsaeure | 54166-74-4

中文名称
——
中文别名
——
英文名称
2'-Carbamoyl-3'-methoxyoxanilsaeure
英文别名
2'-carbamyl-3'-methoxyoxanilic acid;2'-Carbamoyl-3'-methoxyoxanilic acid;2-(2-carbamoyl-3-methoxyanilino)-2-oxoacetic acid
2'-Carbamoyl-3'-methoxyoxanilsaeure化学式
CAS
54166-74-4
化学式
C10H10N2O5
mdl
——
分子量
238.2
InChiKey
MMPCVKPPOCIGHH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    220 °C (decomp)
  • 密度:
    1.490±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.5
  • 重原子数:
    17
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.1
  • 拓扑面积:
    119
  • 氢给体数:
    3
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • SUBSTITUTED 2- AMIDOQUINAZOL-4-ONES AS MATRIX METALLOPROTEINASE-13 INHIBITORS
    申请人:Takeda Pharmaceutical Company Limited
    公开号:US20150329556A1
    公开(公告)日:2015-11-19
    The present invention provides a novel amide derivative having a matrix metalloproteinase inhibitory activity, and useful as a pharmaceutical agent, which is a compound represented by the formula (I) wherein ring A is an optionally substituted, nitrogen containing heterocycle, ring B is an optionally substituted monocyclic homocycle or an optionally substituted monocyclic heterocycle, Z is N or NR 1 (R 1 is a hydrogen atom or an optionally substituted hydrocarbon group), is a single bond or a double bond, R 2 is a hydrogen atom or an optionally substituted hydrocarbon group, X is an optionally substituted spacer having 1 to 6 atoms, ring C is (1) an optionally substituted homocycle or (2) an optionally substituted heterocycle other than a ring represented by (II) (X′ is S, O, SO, or CH 2 ), and at least one of ring B and ring C has substituent(s), provided that N-(1S,2R)-1-(3,5-difluorobenzyl)-3-[(3-ethylbenzyl)amino]2 hydroxypropyl}5,6 dimethyl 4 oxo 1,4 dihydrothieno[2,3-d]pyrimidine-2-carboxamide is excluded, or a salt thereof.
    本发明提供了一种新型酰胺衍生物,具有基质金属蛋白酶抑制活性,并且作为药用剂是有用的,该化合物由以下式(I)表示,其中环A是一个可选择取代的含氮杂环,环B是一个可选择取代的单环同核环或可选择取代的单环杂环,Z是N或NR1(R1是氢原子或可选择取代的碳氢基团),是一个单键或双键,R2是氢原子或可选择取代的碳氢基团,X是一个具有1到6个原子的可选择取代的间隔物,环C是(1)一个可选择取代的同核环或(2)一个除了由(II)表示的环之外的可选择取代的杂环(X′是S、O、SO或CH2),并且环B和环C中至少有一个有取代基,但不包括N-(1S,2R)-1-(3,5-二氟苄基)-3-[(3-乙基苄基)氨基]2-羟基丙基}5,6-二甲基-4-氧代-1,4-二氢噻唑并[2,3-d]嘧啶-2-羧酰胺,或其盐。
  • Oxamic acid derivatives
    申请人:American Home Products Corporation
    公开号:US04160100A1
    公开(公告)日:1979-07-03
    Anti-allergic agents of aromatic and heterocyclic oxamic acid derivation present the following formula: ##STR1## in which A is a member selected from the group consisting of 2-thiazolyl, 2-pyridyl, 2-pyridyl-N-oxide, 6-(lower)alkyl-2-pyridyl, 3-cyano-2-pyridyl, 3-pyridyl, 4-pyridyl, 2-pyrimidinyl, 2-pyrazinyl, .alpha.-naphthyl, .beta.-naphthyl, phenyl, 2,6-di-chlorophenyl, and substituted phenyl moieties containing from one to three substituents in any of the 2,3,4 and 5 positions of the phenyl ring, independently selected from the group consisting of lower alkyl, lower alkylthio, lower alkylsulfinyl, lower alkoxy, hydroxy(lower)alkoxy, 2-(lower alkoxy oxalyloxy) ethoxy, benzyloxy, N-mono-and di-lower alkylamino(lower)alkoxy, halo, sulfamyl, polyhalo(lower)alkyl, carbamyl, N-lower alkylcarbamyl, nitro, mono-and di-lower alkylamino, phenylazo, carboxy, lower alkylcarbonyl, cyano, carb(lower)alkoxy, phenoxy(lower)alkoxy, lower alkoxyoxalamido and lower alkoxyoxalamidophenoxy radicals; B, when taken alone, is a member selected from the group consisting of --OH, lower alkoxy, --NH.sub.2, --NHOH, cyclohexyloxy and phenoxy; and Y is a member selected from the group consisting of oxygen and when taken with B and the carbon atom to which they are attached, forms the moiety ##STR2##
    芳香族和杂环氧酰胺衍生的抗过敏剂具有以下化学式:##STR1## 其中A是从以下组中选择的成员:2-噻唑基、2-吡啶基、2-吡啶-N-氧化物、6-(较低)烷基-2-吡啶基、3-氰基-2-吡啶基、3-吡啶基、4-吡啶基、2-嘧啶基、2-吡嗪基、α-萘基、β-萘基、苯基、2,6-二氯苯基和含有1至3个取代基的取代苯基,这些取代基独立地选自下列组成的组:较低烷基、较低烷硫基、较低烷基亚硫酰基、较低烷氧基、羟基(较低)烷氧基、2-(较低烷氧羰酰氧基)乙氧基、苄氧基、N-单和双较低烷基氨基(较低)烷氧基、卤素、磺酰基、多卤素(较低)烷基、氨基甲酰基、N-较低烷基甲酰基、硝基、单和双较低烷基氨基、苯基偶氮基、羧基、较低烷基羰基、氰基、羰(较低)烷氧基、苯氧基(较低)烷氧基、较低烷氧羰胺基和较低烷氧羰胺苯氧基基团;B单独时,是从以下组成的组中选择的成员:--OH、较低烷氧、--NH.sub.2、--NHOH、环己氧基和苯氧基;Y是从以下组成的组中选择的成员:氧,当与B和它们连接的碳原子一起取得时,形成如下团 ##STR2##
  • Oxamic acid derivatives for the prevention of immediate type
    申请人:American Home Products Corporation
    公开号:US03966965A1
    公开(公告)日:1976-06-29
    Anti-allergic agents of ##EQU1## and heterocyclic oxamic acid derivation present the following formula: IN WHICH A is a member selected from the group consisting of 2-thiazolyl, 2-pyridyl, 2-pyridyl-N-oxide, 6-(lower)alkyl-2-pyridyl, 3-cyano-2-pyridyl, 3-pyridyl, 4-pyridyl, 2-pyrimidinyl, 2-pyrazinyl, .alpha.-naphthyl, .beta.-naphthyl, phenyl, 2,6-dichlorophenyl, and substituted phenyl moieties containing from one to three substituents in any of the 2,3,4 and 5 positions of the phenyl ring, independently selected from the group consisting of lower alkyl, lower alkylthio, lower alkylsulfinyl, lower alkoxy, hydroxy(lower)-alkoxy, 2-(lower alkoxy oxalyloxy) ethoxy, benzyloxy, N-mono-and di-lower alkylamino(lower)-alkoxy, halo, sulfamyl, polyhalo(lower)alkyl, carbamyl, N-lower alkylcarbamyl, nitro, mono- and di-lower alkylamino, phenylazo, carboxy, lower alkylcarbonyl, cyano, carb(lower)alkoxy, phenoxy(lower)alkoxy, lower alkoxyoxalamido and lower alkoxyoxalamidophenoxy radicals; B, when taken alone, is a member selected from the group consisting of -OH, lower alkoxy, --NH.sub.2, --NHOH, cyclohexyloxy and phenoxy; and Y is a member selected from the group consisting of oxygen and when taken with B and the carbon atom to which they are attached, forms the moiety ##EQU2##
    ##EQU1##的抗过敏剂和杂环氧酰胺衍生物具有以下公式:其中A是从2-噻唑基,2-吡啶基,2-吡啶-N-氧化物,6-(较低)烷基-2-吡啶基,3-氰基-2-吡啶基,3-吡啶基,4-吡啶基,2-吡嘧啶基,2-吡啶基,α-萘基,β-萘基,苯基,2,6-二氯苯基和取代苯基等组成的群中选择的成员,其中该苯环的2,3,4和5位置中的任意位置都包含从一个到三个取代基的取代基,这些取代基独立地从较低烷基,较低硫代烷基,较低磺酰基,较低烷氧基,羟基(较低)-烷氧基,2-(较低烷氧基氧代羰基)乙氧基,苄氧基,N-单和二-较低烷基氨基(较低)-烷氧基,卤素,磺酰基,多卤代(较低)烷基,氨基甲酰基,N-较低烷基氨基甲酰基,硝基,单和双-较低烷基氨基,苯基偶氮基,羧基,较低烷基羰基,氰基,羰基(较低)烷氧基,苯氧基(较低)烷氧基,较低烷氧氧代草酰胺基和较低烷氧氧代草酰胺苯氧基自由基;B,当单独取时,是从-OH,较低烷氧基,-NH.sub.2,-NHOH,环己氧基和苯氧基等组成的群中选择的成员;Y是从氧中选择的成员,当与B和它们连接的碳原子一起取时,形成上述公式。
  • 2 Alkoxyoxamoyl-pyrazines
    申请人:American Home Products Corporation
    公开号:US04036837A1
    公开(公告)日:1977-07-19
    Anti-allergic agents of aromatic and heterocyclic oxamic acid derivation present the following formula: ##STR1## in which A is a member selected from the group consisting of 2-thiazolyl, 2-pyridyl, 2-pyridyl-N-oxide, 6-(lower)alkyl-2-pyridyl, 3-cyano-2-pyridyl, 3-pyridyl, 4-pyridyl, 2-pyrimidinyl, 2-pyrazinyl, .alpha.-naphthyl, .beta.-naphthyl, phenyl, 2,6-dichlorophenyl, and substituted phenyl moieties containing from one to three substituents in any of the 2,3,4 and 5 positions of the phenyl ring, independently selected from the group consisting of lower alkykl, lower alkylthio, lower alkylsulfinyl, lower alkoxy, hydroxy(lower)alkoxy, 2-(lower alkoxy oxalyloxy) ethoxy, benzyloxy, N-mono- and di-lower alkylamino(lower)alkoxy, halo, sulfamyl, polyhalo(lower)alkyl, carbamyl, N-lower alkylcarbamyl, nitro, mono- and di-lower alkylamino, phenylazo, carboxy, lower alkylcarbonyl, cyano, carb(lower)alkoxy, phenoxy(lower)alkoxy, lower alkoxyoxalamido and lower alkoxyoxalamidophenoxy radicals; B, when taken alone, is a member selected from the group consisting of --OH, lower alkoxy, --NH.sub.2, --NHOH, cyclohexyloxy and phenoxy; and Y is a member selected from the group consisting of oxygen and when taken with B and the carbon atom to which they are attached, forms the moiety ##STR2##
    芳香族和杂环氧酰胺衍生的抗过敏剂具有以下公式:##STR1## 其中A是从2-噻唑基,2-吡啶基,2-吡啶-N-氧化物,6-(较低)烷基-2-吡啶基,3-氰基-2-吡啶基,3-吡啶基,4-吡啶基,2-嘧啶基,2-吡嗪基,α-萘基,β-萘基,苯基,2,6-二氯苯基和含有1-3个取代基的取代苯基中选择的成员,独立地从低烷基,低烷基硫基,低烷基亚磺酰基,低烷氧基,羟基(低)烷氧基,2-(低烷氧羰基)乙氧基,苄氧基,N-单和二-低烷基氨基(低)烷氧基,卤,磺酰基,多卤(低)烷基,氨基甲酰基,N-低烷基氨甲酰基,硝基,单和二-低烷基氨基,苯基偶氮基,羧基,低烷基羰基,氰基,羰(低)烷氧基,苯氧(低)烷氧基,低烷氧乙酰胺和低烷氧乙酰胺苯氧基自由基中独立选择的成员;当单独取B时,B是从--OH,低烷氧基,--NH.sub.2,--NHOH,环己氧基和苯氧基中选择的成员;当与B和它们附着的碳原子一起取时,Y是从氧中选择的成员,并形成以下基团##STR2##
  • Pyrimidinyl oxamic acids and esters, and compositions and methods for
    申请人:American Home Products Corporation
    公开号:US04054657A1
    公开(公告)日:1977-10-18
    Anti-allergic agents of aromatic and heterocyclic oxamic acid derivation present the following formula: ##STR1## in which A is a member selected from the group consisting of 2-thiazolyl, 2-pyridyl, 2-pyridyl-N-oxide, 6-(lower)alkyl-2-pyridyl, 3-cyano-2-pyridyl, 3-pyridyl, 4-pyridyl, 2-pyrimidinyl, 2-pyrazinyl, .alpha.-naphthyl, .beta.-naphthyl, phenyl, 2,6-di-chlorophenyl, and substituted phenyl moieties containing from one to three substituents in any of the 2,3,4 and 5 positions of the phenyl ring, independently selected from the group consisting of lower alkyl, lower alkylthio, lower alkylsulfinyl, lower alkoxy, hydroxy(lower)alkoxy, 2-(lower alkoxy oxalyloxy) ethoxy, benzyloxy, N-mono-and di-lower alkylamino(lower)alkoxy, halo, sulfamyl, polyhalo(lower)alkyl, carbamyl, N-lower alkylcarbamyl, nitro, mono-and di-lower alkylamino, phenylazo, carboxy, lower alkylcarbonyl, cyano, carb(lower)alkoxy, phenoxy(lower)alkoxy, lower alkoxyoxalamido and lower alkoxyoxalamidophenoxy radicals; B, when taken alone, is a member selected from the group consisting of --OH, lower alkoxy, --NH.sub.2, --NHOH, cyclohexyloxy and phenoxy; and Y is a member selected from the group consisting of oxygen and when taken with B and the carbon atom to which they are attached, forms the moiety ##STR2##
    芳香族和杂环氧酰胺衍生的抗过敏药物具有以下式子:##STR1## 其中A是从以下组中选出的一种成员:2-噻唑基,2-吡啶基,2-吡啶基-N-氧化物,6-(较低)烷基-2-吡啶基,3-氰基-2-吡啶基,3-吡啶基,4-吡啶基,2-嘧啶基,2-吡嗪基,α-萘基,β-萘基,苯基,2,6-双氯苯基和含有1-3个取代基的取代苯基,这些取代基分别独立地选自以下组:较低烷基,较低硫代烷基,较低磺代烷基,较低烷氧基,羟基(较低)烷氧基,2-(较低烷氧羰基)乙氧基,苄氧基,N-单-和二-较低烷基氨基(较低)烷氧基,卤素,磺酰基,多卤(较低)烷基,氨基甲酰基,N-较低烷基氨基甲酰基,硝基,单-和二-较低烷基氨基,苯基偶氮基,羧基,较低烷基羰基,氰基,羟基苯氧基,较低烷氧基草酰胺基和较低烷氧基草酰胺基苯氧基基团;当单独取B时,B是从以下组中选出的一种成员:--OH,较低烷氧基,--NH.sub.2,--NHOH,环己氧基和苯氧基;当与B和它们所连接的碳原子一起取时,Y是从以下组中选出的一种成员:氧和形成基团##STR2##
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐